| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Testing revenue | $106.97M | $109.54M | $112.15M | $107.31M | $122.26M | $127.76M | $135.83M | $135.09M |
| Other Testing Revenue | $4M | $3.1M | $1.8M | $400K | $1.8M | $1.5M | $2.5M | $4.2M |
| Product revenue | $3.91M | $3.19M | $3.02M | $3.58M | $3.6M | $3.3M | $3.85M | $3.68M |
| Biopharmaceutical and other revenue | $3.55M | $3.14M | $3.46M | $3.58M | $4.3M | $815K | $962K | $301K |
| Biopharmaceutical revenue | $1.7M | $2.04M | $1.19M | $2.3M | $2.63M | $646K | $963K | $301K |
| Contract manufacturing and testing | $1.85M | $1.1M | $2.27M | $1.29M | $1.67M | $169K | $0 | $0 |
| Total | $114.43M | $115.86M | $118.63M | $114.47M | $130.16M | $131.87M | $140.64M | $139.07M |